Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Jernigan Capital, Inc. JCAP breached their fiduciary duties or violated the federal securities laws in connection with the company's merger with NexPoint Advisors, L.P.
Click here to learn more and participate in the action.
On August 3, 2020, Jernigan announced that it had signed an agreement to be acquired by NexPoint Advisors for approximately $900 million. Pursuant to the merger agreement, Jernigan's stockholders will receive $17.30 in cash for each share of Jernigan common stock owned. The deal is scheduled to close in the fourth quarter of 2020.
Bragar Eagel & Squire is concerned that Jernigan's board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price. Indeed, Jernigan shares have recently traded well above the merger consideration of $17.30 per share. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Jernigan's stockholders.
If you own shares of Jernigan and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at investigations@bespc.com or telephone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200803005615/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.